Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02782819Unknown
Randomised, open-label trial of albumin (human) and gelatin in Shock and hypotension (2 arms), sponsored by Mahidol University. Primary endpoint: Proportion of patients who had shock reversal at 6 hours. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02782819.